An investigational vaccine that targets common KRAS mutations induced durable immune responses among individuals at high risk ...

The vaccine spurs a lasting immune response in people at a high risk for pancreatic cancer. Whether it staves off the disease remains to be seen.

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer that is often diagnosed at advanced stages and carries a low ...

Phase 1 clinical trial results of a KRAS-targeting vaccine for pancreatic ductal adenocarcinoma show it is safe and can ...

ART5 is designed to address the most common root cause of ADPKD by targeting PKD1, potentially restoring PC1 production in approximately 85% of ...

A first-in-human KRAS-targeted pancreatic cancer vaccine elicited durable immune responses in 90% of participants, and slowed precancerous lesions.

Omnitrope 5 mg/1.5 mL somatropin after receiving complaints of cracked and leaking glass cartridges. Cracked and leaking ...

Andy Young, 62, was diagnosed after noticing some mild flu-like symptoms ...

He warned that most of the weight loss advice we get is "wrong" ...

A team of researchers in the US has conducted an initial experimental trial with 20 subjects to demonstrate that immunization ...

After a promising Phase I read out on mKRAS-VAX in patients with hereditary cancer predisposition and pancreatic lesions, ...

There may be a genetic link for some people who experience ovarian cysts. They can also be related to conditions like endometriosis and PMOS, formerly known as PCOS, which may have a genetic component ...